Clemastine

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Substance from the group of H 1 antagonists.

Half-life
This section has been translated automatically.

8,1 h

Indication
This section has been translated automatically.

Acute allergic reactions, anaphylactic shock, prophylaxis of contrast medium allergies as well as histamine-related complications in anaesthesia and gastric function diagnostics.

Limited indication
This section has been translated automatically.

Pregnancy, lactation, stenosing stomach ulcer, pyloroduodenal obstruction, bladder neck obstruction.

Dosage and method of use
This section has been translated automatically.

  • 2 times 1 mg/day p.o. or 2 times 2 mg/day i.v.
  • Children 6-12 years: 2 times 0.5-1 mg/day p.o.
  • Children 3-6 years: 2 times 2 teaspoons of syrup/day p.o.
  • Children 1-3 years: 2 times 1 teaspoon syrup/day p.o.

Undesirable effects
This section has been translated automatically.

Sedation, central nervous system problems, dry mouth.

Interactions
This section has been translated automatically.

Enhancing the effect of centrally attenuating drugs and alcohol, MAO inhibitors prolong and intensify the effect of clemastine.

Contraindication
This section has been translated automatically.

Infancy, prostate hypertrophy, narrow angle glaucoma, paragroup allergy (syrup).

Preparations
This section has been translated automatically.

Tavegil

Patientinformation
This section has been translated automatically.

Remember! The medication leads to an impairment of the ability to react (participation in traffic, operation of machines)!

Outgoing links (1)

Antihistamines;

Authors

Last updated on: 29.10.2020